Validation study of German inpatient administrative health data for epidemiological surveillance and measurement of quality of care for sepsis: the OPTIMISE study protocol by Schwarzkopf, Daniel et al.
1Schwarzkopf D, et al. BMJ Open 2020;10:e035763. doi:10.1136/bmjopen-2019-035763
Open access 
Validation study of German inpatient 
administrative health data for 
epidemiological surveillance and 
measurement of quality of care for 
sepsis: the OPTIMISE study protocol
Daniel Schwarzkopf   ,1,2 Carolin Fleischmann- Struzek,1,3 Peter Schlattmann,4 
Heike Dorow,2 Dominique Ouart,2 Andreas Edel,5 Falk A Gonnert,6 Jürgen Götz,7 
Matthias Gründling,8 Markus Heim,9 Ulrich Jaschinski,10 Simone Lindau,11 
Patrick Meybohm   ,12 Christian Putensen,13 Michael Sander,14 Konrad Reinhart,2,5 
OPTIMISE study group
To cite: Schwarzkopf D, 
Fleischmann- Struzek C, 
Schlattmann P, et al.  Validation 
study of German inpatient 
administrative health data for 
epidemiological surveillance 
and measurement of quality of 
care for sepsis: the OPTIMISE 
study protocol. BMJ Open 
2020;10:e035763. doi:10.1136/
bmjopen-2019-035763
 ► Prepublication history and 
additional material for this 
paper are available online. To 
view these files, please visit 
the journal online (http:// dx. doi. 
org/ 10. 1136/ bmjopen- 2019- 
035763).
Received 05 December 2019
Revised 22 April 2020
Accepted 09 July 2020
For numbered affiliations see 
end of article.
Correspondence to
Dr Daniel Schwarzkopf;  
 Daniel. Schwarzkopf@ med. uni- 
jena. de
Protocol
© Author(s) (or their 
employer(s)) 2020. Re- use 
permitted under CC BY- NC. No 
commercial re- use. See rights 
and permissions. Published by 
BMJ.
ABSTRACT
Introduction Sepsis is a major cause of preventable 
deaths in hospitals. This study aims to investigate if sepsis 
incidence and quality of care can be assessed using 
inpatient administrative health data (IAHD).
Methods and analysis Design: Retrospective 
observational validation study using routine data to assess 
the diagnostic accuracy of sepsis coding in IAHD regarding 
sepsis diagnosis based on medical record review. 
Procedure: A stratified sample of 10 000 patients with an 
age ≥15 years treated in between 2015 and 2017 in 10 
German hospitals is investigated. All available information 
of medical records is screened by trained physicians to 
identify true sepsis cases (‘gold standard’) both according 
to current (‘sepsis-1’) definitions and new (‘sepsis-3’) 
definitions. Data from medical records are linked to IAHD 
on patient level using a pseudonym. Analyses: Proportions 
of cases with sepsis according to sepsis-1 and sepsis-3 
definitions are calculated and compared with estimates 
from coding of sepsis in IAHD. Predictive accuracy 
(sensitivity, specificity) of different coding abstraction 
strategies regarding the gold standard is estimated. 
Predictive accuracy of mortality risk factors obtained from 
IAHD regarding the respective risk factors obtained from 
medical records is calculated. An IAHD- based risk model 
for hospital mortality is compared with a record- based 
risk model regarding model- fit and predicted risk of 
death. Analyses adjust for sampling weights. The obtained 
estimates of sensitivity and specificity for sepsis coding in 
IAHD are used to estimate adjusted incidence proportions 
of sepsis based on German national IAHD.
Ethics and dissemination The study has been 
approved by the ethics commission of the Jena University 
Hospital (No. 2018-1065- Daten). The results of the 
study will be discussed in an expert panel to write 
a memorandum on improving the utility of IAHD for 
epidemiological surveillance and quality management of 
sepsis care.
Trial registration number DRKS00017775; Pre- results.
INTRODUCTION
Sepsis is final pathway to death from infec-
tious diseases,1 causing more than 6 million 
deaths worldwide.2 It is among the most 
expensive conditions treated in hospital,3 and 
was regarded a major cause of preventable 
deaths in hospitals.4 5 Recognising shortcom-
ings in prevention, diagnosis and treatment 
of sepsis, a resolution was released by WHO 
in May 2017. It urges member states—among 
other points—to improve epidemiological 
surveillance as well as quality of care.6 7
Administrative health data are widely used 
for disease surveillance, outcome research 
and health services research, since they 
allow an easy investigation of whole popu-
lations.8 Epidemiological studies on sepsis 
Strengths and limitations of this study
 ► The results of the study will allow to calculate adjust-
ed estimates of true sepsis incidence for Germany.
 ► The study uses a multicentre validation sample of 
inpatient cases that allows assessment of both sen-
sitivity and specificity of several coding abstraction 
strategies for sepsis.
 ► Based on its multicentre sample, the study can 
investigate the variability in sepsis coding across 
hospitals.
 ► Based on the study personnel necessary to conduct 
the study only tertiary care and university hospitals 
participate in the study, restricting generalisability of 
results.
 ► True sepsis cases are identified by a retrospective 
review of medical chart and not by prospectively 
gathered data, which could cause a limitation of in-
ternal validity.
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have been conducted relying on administrative health 
data both in the USA9 10 and Germany.11 12 Administra-
tive data are also commonly used for the purpose of 
measuring quality of care.13 Several models for assessing 
risk- adjusted sepsis- related mortality based on admin-
istrative data have been proposed in the USA14 15 and 
Germany.16
When using administrative data for these purposes, 
the validity of the method to identify patients with the 
disease of interest is of high importance, since a misclas-
sification bias might threaten the validity of study conclu-
sions.8 Additionally, knowing sensitivity and specificity of 
an identification method allows for an adjusted estima-
tion of the true number of sepsis cases in a population.17 
Several methods have been reported to identify sepsis in 
inpatient administrative health data (IAHD). These are 
based on abstraction of International Classification of 
Diseases (ICD) codes. Some define sepsis by the pres-
ence of specific codes for sepsis (eg, A41.0 for Sepsis due 
to Staphylococcus aureus, or R65.1 for systemic inflamma-
tory response syndrome of infectious origin with organ 
failure (severe sepsis)). Others use algorithms that define 
sepsis by the concurrent presence of a code for sepsis or 
other infections (eg, I30—for acute pericarditis) with 
codes for organ dysfunctions (eg, N17—for Acute kidney 
failure).9 10 18 The validity of different methods has been 
investigated in comparison to a gold- standard diagnosis 
mostly derived by review of medical charts. A systematic 
review revealed an overall low validity and high hetero-
geneity across different coding abstraction strategies 
and data sources.18 Beside our own single- centre pilot 
study, the validity of sepsis coding in German IAHD has 
yet not been studied.19 Additionally, previous studies did 
not investigate how validly sepsis- related risk- adjusted 
mortality can be derived from IAHD.
In 2016, new clinical definitions of sepsis (‘sepsis-3’) 
were introduced.1 These sepsis definitions exclude any 
sepsis without organ dysfunction and changed the criteria 
for the presence of organ dysfunction. Guidelines for 
ICD coding of sepsis in IAHD continued to rely on the 
old sepsis definitions (‘sepsis-1’) for several years (eg, 
in Germany, coding guidelines were changed in 2020). 
Thus, no estimates on the incidence of sepsis-3 in compar-
ison to sepsis-1 definitions are yet available for Germany.
Based on these considerations, two interlinked studies 
are conducted: a validation study and a national inci-
dence study. The validation study has the aims (1) to 
investigate the validity (sensitivity, specificity) of different 
coding abstraction strategies to identify sepsis in IAHD, 
(2) to identify possible causes of undercoding and over-
coding of sepsis in IAHD and (3) to investigate the 
validity of models to calculate risk- adjusted mortality 
based on IAHD. Using sensitivity and specificity of coding 
abstraction strategies obtained by the validation study, 
the national incidence study has the aim (4) to obtain 
adjusted estimates of the incidence of hospital treated 
sepsis in Germany both according to sepsis-1 and sepsis-3 
definitions.
METHODS AND ANALYSIS
The investigator initiated study ‘Validation and optimi-
sation of the utility of routine data for improving the 
quality of sepsis management in hospitals’ (Validierung 
und Optimierung der Nutzbarkeit von Routinedaten zur 
Qualitätsverbesserung des Sepsis- Managements im Kran-
kenhaus—OPTIMISE) is funded by governmental public 
funds between September 2018 and October 2020. This 
study protocol takes into account the recommendations 
of the statement on the Reporting of studies Conducted 
using Observational Routinely collected health Data 
(RECORD)20 and of a version of the Standards for 
Reporting of Diagnostic accuracy (STARD) adapted to 
validation studies of health administrative data.8 The 
checklists are given as online supplementary materials 
1 and 2. Two separate but interlinked studies will be 




A multicentre, retrospective, observational valida-
tion study using IAHD and a medical chart review is 
conducted. Based on IAHD of ten German hospitals, 
a sample of 1000 medical records per hospital of inpa-
tient cases of the years 2015–2017 is investigated. For 
these 10 000 hospital episodes all available information of 
medical records is screened to identify true sepsis cases 
(‘gold standard’) both according to current (‘sepsis-1’) 
definitions21 and newly proposed (‘sepsis-3’) definitions.1 
The validity of sepsis case identification based on coding 
in IAHD is then assessed by comparing it to the informa-
tion based on clinical judgement of medical records.
Setting
Ten German hospitals participate in the study. Eight 
of the hospitals are university hospitals. The two non- 
university hospitals are teaching hospitals providing 
tertiary level care, one is in public and one in private 
ownership. The mean number of beds for inpatient care 
is 1388 (minimum: 755, maximum: 3000).
Sample
This study includes hospital episodes of patients, which 
received inpatient care, were billed according to the 
German diagnosis- related groups (DRG) system, and 
were at least 15 years of age at time of admission. Based 
on the IAHD provided by the ten participating hospi-
tals, a sample of 1200 hospital episodes per hospital is 
drawn. Since the rate of sepsis among hospital cases is 
only about 2%,11 12 19 a disproportional stratified sampling 
is conducted to increase the proportion of ‘true’ sepsis 
cases in the sample. The strata are defined by the cross- 
tabulation of the following criteria: (1) presence of a 
procedure code (Operationen- und Prozedurenschlüssel; 
OPS) for complex intensive care treatment (yes vs no, 
OPS- code: 8–890); (2) hospital length of stay (≤6 days vs 
>6 days), (3) year of discharge (2015–2017). The same 
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number of cases is sampled from each of the resulting 
12 strata. The strata were chosen based on the experi-
ences from a single- centre pilot study, where the rate of 
cases with sepsis in a sample obtained by this method was 
16%.19 The aim of the study is to analyse 1000 episodes 
per hospital, 200 additional episodes are sampled, since 
some medical records might be unavailable for analysis by 
the local study teams.
Procedure
After applying the inclusion criteria, the ten participating 
hospitals transfer pseudonymised IAHD of the respective 
hospital to the study’s epidemiologist at the University 
Hospital Jena. Sampling of cases is done and pseudonyms 
of sampled cases are reported back to the study centres.
To identify cases with sepsis, a combination of criteria 
needs to be fulfilled. To judge these criteria, study physi-
cians need to review (1) information on the presence of 
infection (clinical signs or results of microbiology), as 
well as (2) information on specific symptoms, vital signs 
and laboratory values, which might indicate a criterion 
of a systematic inflammatory response syndrome (SIRS) 
or of an organ dysfunction (see table 1). Finally, a causal 
link between (1) and (2) needs to be highly probable 
based on the available information. Study physicians are 
not informed about which ICD-10 codes are present in 
the IAHD, but they cannot be blinded to ICD-10 codes 
that might be present within the medical records. For 
purpose of training of study physicians to identify cases 
with sepsis from medical records, 40 cases are sampled 
per study centre including 20 cases with coded sepsis with 
organ dysfunction or septic shock according to sepsis-1 
(ICD-10- German Modification (GM) codes R65.1 or 
R57.2), 10 cases with coding of any other infection and 10 
cases without any infection code. Based on the structured 
electronic case report form (eCRF), a written working 
instruction, and a training session, all local study physi-
cians (at least two necessary) of the centres screen and 
discuss every of the 40 cases, of which five are monitored 
by the study physician of the core study team. After the 
training, a second sample of 40 cases is provided to assess 
the objectivity of the identification method. These cases 
are screened independently by two trained study physi-
cians and information on sepsis criteria is documented in 
an eCRF. To assess objectivity of the process of identifying 
cases with sepsis, the inter- rater agreement is calculated. If 
the objectivity for identifying cases with sepsis with organ 
dysfunction (sepsis-1) in a study centre is below the cut- 
off of 0.6, a second monitoring of five cases is conducted.
After the training and validation phase is finished, 
the stratified sampling of 1200 cases per study centre is 
conducted (flow diagram presented in figure 1). The 
records of these cases are screened in random order to 
avoid bias by learning effects. Each study centre needs to 
document at least 1000 cases. Study physicians document 
sepsis criteria according to sepsis-1 and sepsis-3 defini-
tions via the eCRF. For cases with sepsis additional clinical 
Table 1 Defining criteria for status according sepsis-1 and sepsis-3 definitions for review of medical records
Criteria* Status according to sepsis-1
SIRS- negative 
sepsis
Status according to 
sepsis-3
  Sepsis 
without organ 
dysfunction







Presence of infection Yes Yes Yes Yes Yes Yes
Co- occurrence of at least two 
of four SIRS criteria
Yes Yes Yes No     
At least one newly occurring 
organ dysfunction caused by 
infection
No Yes   Yes†     
Arterial hypotension caused 
by infection
No No Yes     
Increase of SOFA score by at 
least two points caused by 
infection
        Yes   
Co- occurrence of arterial 
hypotension and increase of 
lactate >2 mmol/L
          Yes
Table presents the criteria that have to be present to define the status of a case according to current sepsis-1 definitions21 and newly 
proposed sepsis-3 definitions.1 The status of SIRS- negative sepsis was suggested by Kaukonen et al26 Criteria with a ‘yes’ in the same 
column need to be present simultaneously while at the same time criteria with a no need to be not present (logical ‘and’), cells left blank are 
irrelevant for the respective status (can or cannot be present).
*Detailed definitions of each criteria of the definitions are given in the respective literature.1 21
†Either arterial hypotension or other organ dysfunctions caused by infection are present.
SIRS, systematic inflammatory response syndrome; SOFA, sepsis- related organ failure assessment.
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information is documented. Finally, the data managers of 
the core study team at the University Hospital Jena docu-
ment how the sepsis-1 status of cases was according to the 
coding in IAHD in the eCRF of every case. This is done 
after the eCRF parts on sepsis criteria according to medical 
records is completed by the local study physicians. The 
eCRF automatically does a comparison between sepsis-1 
according to records and sepsis-1 according to coding. If 
false positive coding of sepsis has occurred, local study 
nurses are demanded to document possible reasons for 
that. After documentation of cases is finished, data from 
the eCRF are exported and then linked with the IAHD via 
the pseudonym.
Data sources
Inpatient administrative health data
The IAHD contain: patient demographics, reasons 
and type of admission, ICD-10- GM coded primary and 
secondary diagnoses, conducted surgeries and proce-
dures using procedure codes, treating hospital depart-
ments, discharge destinations (including hospital death) 
and billing information. The data are limited, since they 
provide no dates for diagnoses coded in ICD-10- GM. 
Therefore, it cannot be identified, if a diagnosis was 
present at admission. Additionally, they do not contain 
follow- up information after hospital discharge. DRG data 
that can be accessed via the Federal Bureau of Statis-
tics (‘national IAHD’) do not contain information on 
which hospital episodes belong to the same patient and 
also concatenate some successive episodes to one case 
based on specific billing rules (eg, readmission for the 
same primary cause). Since the results of the study shall 
be generalisable to German national IAHD, the IAHD of 
the participating hospitals are provided without consid-
ering which episodes belong to the same patient and with 
concatenated episodes.
Medical record data
All clinical information contained in the medical records 
of the respective cases is screened to identify patients with 
sepsis; this involves information form the patient data 
management system, electronic charts as well as paper 
charts, laboratory data, results of medical imaging and 
other tests, and discharge letters. Study physicians and 
nurses are demanded not to inspect the IAHD coding 
for identification of cases for sepsis. Data from medical 
records are documented in an eCRF using the open 
source study management software OpenClinica (V.3.1).
Data linkage
IAHD are pseudonymised within the participating hospi-
tals. The pseudonym is used to identify the cases within 
the eCRF and thereby to link the data from medical 
records with the information obtained from the IAHD. 
To assure correct linkage patients’ age, gender, exact 
time of admission and discharge obtained from IAHD 
is provided to the study centres additional to the pseud-
onym. By comparing this information (age, sex, admis-
sion and discharge date) with the information provided 
via the eCRF the evaluation of the correctness of the 
linkage is done by the data managers and an epidemiolo-
gist at the University Hospital Jena.
Measures
Measures based on medical records
The eCRF of the study was developed based on previous 
research18 22–25 as well as an own pilot study.19 The complete 
CRF is presented in online supplementary material 3. It 
contains three parts. Part A is documented by trained 
study physicians and aims to identify patients with sepsis. 
If an infection was present, characteristics of the infection 
as well as sepsis criteria are documented. Table 1 pres-
ents the defining criteria for sepsis according to current 
sepsis-121 and newly proposed sepsis-31 definitions. Addi-
tional to the sepsis-1 definition this study also defines the 
status of infection with infection- related organ dysfunc-
tion or infection- related shock without at least two SIRS 
criteria (‘SIRS- negative sepsis’). This is done because the 
validity of the necessity of presence of at least two SIRS 
criteria has been challenged,26 and we want to estimate 
the prevalence of such cases. All criteria are documented 
separately. It is also documented if there is not enough 
information in the medical records to judge if a criterion 
is fulfilled. Based on logical combination of the criteria, 
the eCRF automatically reports to the study physician the 
sepsis-1 and sepsis-3 status or the case. To finalise the iden-
tification of cases with sepsis, the study physician needs 
to confirm this status. Further data are only documented 
for patients with sepsis (either according to sepsis-1, SIRS- 
negative sepsis or sepsis-3) by local study nurses in part B 
of the eCRF and has several purposes.
First, the patient and the course of treatment are 
described (basic demographics, reasons for admission, 
organ replacement therapies). Second, risk factors that 
can also be identified based on IAHD16 are documented 
Figure 1 Flow diagram of the validation study.
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to serve as a gold standard of comparison: comorbidities 
according to the categories of Charlson and Elixhauser 
indices,27–29 pre- existing illnesses or conditions that 
are associated with immunosuppression or increased 
mortality risk (asplenia, transplanted organ status, 
tracheostomy status, dependence on renal replacement 
therapy), treatment in the current hospital episode 
associated with increased mortality risk (chemotherapy, 
stroke treatment, palliative care). Additional risk 
factors and factors influencing mortality, which are 
not available from IAHD are documented: cardiopul-
monary resuscitation occurring before onset of sepsis, 
and presence, type and timing of therapy limitations. 
Results of microbiological diagnostics are documented 
to identify sepsis- related pathogens and as a standard of 
comparison to evaluate the validity of pathogen specific 
ICD-10- GM codes for sepsis present in the IAHD. 
Because knowledge about the importance of sepsis as 
cause of death has only been systematically investigated 
in one study in the USA,25 study physicians also judge 
if sepsis was the immediate cause of death, and what 
primary underlying cause of death was present. Finally, 
to identify the influence of physician documentation 
in records for false negative coding of sepsis in IAHD, 
study physicians document if a diagnosis of sepsis was 
present anywhere in the medical record.
The final part C of the eCRF has the purpose to 
document reasons for false positive coding of sepsis. 
False positive coding occurred, if an ICD-10- GM code 
for sepsis was present, but no sepsis was judged to be 
present based on records, or if an ICD-10- GM code 
for organ dysfunction or shock was present, but only 
a sepsis without organ dysfunction was diagnosed 
according to records. In case of discrepancy, the eCRF 
demands the study nurses to document if SIRS criteria, 
criteria for organ dysfunctions or criteria for a shock 
were present without being related to an infection, 
since this might have caused the false negative coding 
of sepsis.
Measures based on IAHD
IAHD are used to identify the sepsis status of patients 
based on several coding abstraction strategies. The 
primary interest is on the identification of patients with 
sepsis with organ dysfunction including septic shock by 
the ICD-10- GM codes R65.1 and R57.2. Table 2 presents 
all coding abstraction strategies. Parts of the strategies use 
explicit sepsis codes, and parts of the strategies combine 
codes for infection or sepsis with codes for organ dysfunc-
tion, which is known as the implicit coding strategy.9 The 
strategies have been partly adapted from the ICD-922 to 
ICD-10- GM and investigated in a pilot study.19 Surpassing 
previous literature, it will also be tested if the inclusion 
of procedure codes for organ supporting therapies to 
define organ dysfunction will enhance predictive validity. 
Respective procedure codes will be defined and all codes 
relevant for the abstraction strategies will be checked and 
if necessary revised before the primary analyses of the 
study will be conducted.
Table 2 Coding abstraction strategies for identification of sepsis status according to sepsis-1 in administrative health data
Coding abstraction strategy Sepsis status Definition
Explicit sepsis coding Sepsis without organ dysfunction Presence of any explicit ICD-10- GM sepsis codes 
with R57.2 and R65.1 not being present
Sepsis with organ dysfunction 
without shock
Presence of ICD-10- GM R65.1 but not R57.2
Septic shock Presence of ICD-10- GM R57.2
Sepsis with organ dysfunction 
including shock
Presence of ICD-10- GM R65.1 or R57.2
Sepsis Presence of any explicit ICD-10- GM sepsis code
Explicit sepsis coding and organ 
dysfunction codes
Sepsis with organ dysfunction 
including shock
Presence of any explicit ICD-10- GM sepsis code and 
any ICD-10- GM code for organ dysfunction
Implicit approach Sepsis with organ dysfunction 
including shock
Presence of any ICD-10- GM code for infection and 
any ICD-10- GM code for organ dysfunction
Explicit sepsis coding and organ 
dysfunction codes including 
procedure codes
Sepsis with organ dysfunction 
including shock
Presence of any ICD-10- GM sepsis code and (any 
ICD-10- GM code for organ dysfunction or any OPS 
code for organ dysfunction*)
Implicit approach including 
procedure codes
Sepsis with organ dysfunction 
including shock
Presence of any ICD-10- GM code for infection and 
(any ICD-10- GM code for organ dysfunction or any 
OPS code for organ dysfunction*)
ICD-10- GM explicit sepsis codes, infection codes and codes for organ dysfunction are presented in online supplementary material 4.
*OPS codes for identification of organ dysfunctions will be identified before conduction of the main analyses and documented in the analyses 
plan.
ICD-10- GM, International Classification of Diseases, 10 Revision, German Modification; OPS, Operationen- und Prozedurenschlüssel 
(German classification of surgeries and procedures).
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Statistical analysis
As a measure of objectivity inter- rater agreement is calcu-
lated between two independent study physicians per study 
centre based on 40 medical records of the validation 
phase. Inter- rater agreement is calculated by Gwet’s AC1, 
which is a more robust alternative to Cohen’s Kappa.30 
Primary aim of the validation phase is to achieve at least 
a substantial inter- rater agreement above 0.631 regarding 
the judgement of the presence of sepsis with organ 
dysfunction including septic shock (sepsis-1). Inter- rater 
agreement is also calculated regarding the full classifi-
cation of sepsis status (sepsis-1: no sepsis, sepsis without 
organ dysfunction, sepsis with organ dysfunction but no 
shock, septic shock; sepsis-3: no sepsis, sepsis without 
shock, septic shock).
Based on the main study involving 1000 medical 
records per study centre proportions are calculated for 
sepsis and sepsis subgroups according to sepsis-1 and 
sepsis-3 definition (sepsis with and without organ dysfunc-
tion and septic shock), as well as for sepsis according to 
the different coding abstraction strategies. Differences 
between the different definitions and coding strategies 
will be investigated by cross- tabulation. Severity of illness 
might differ between gold- standard sepsis cases and 
coded sepsis cases.32 33 Therefore, indicators of illness 
severity and hospital mortality will be compared between 
the different groups.
The performance of the different coding abstrac-
tion strategies for identification of sepsis and different 
subgroups of sepsis-1 and sepsis-3 in IAHD will be 
assessed. Dichotomous classification problems like pres-
ence of sepsis with organ dysfunction (including septic 
shock, sepsis-1) or presence of sepsis (including septic 
shock, sepsis-3) will be assessed by sensitivity, specificity, 
positive and negative predictive value. Classification with 
more than two groups (sepsis-1: no sepsis, sepsis without 
organ dysfunction, sepsis with organ dysfunction but no 
shock, septic shock; sepsis-3: no sepsis, sepsis without 
shock, septic shock) will be assessed by Cohen’s κ (or 
similar measures) and performance measures for multi-
class classification like microaveraged and macroaver-
aged F- scores.34 Primary outcome is the sensitivity of the 
explicit coding of sepsis with organ dysfunction including 
septic shock (ICD-10- GM codes R65.1 and R57.2).
The presence of different pathogens that are identi-
fied to be sepsis- related by review of medical records is 
cross- tabulated with the ICD-10- GM coding of pathogen- 
specific sepsis in IAHD to assess the validity of the coding.
Finally, the validity of risk- adjusted mortality calculation 
based on IAHD is assessed. Risk factors that can be iden-
tified both based on review of records as well as on IAHD 
are cross- tabulated and the diagnostic accuracy of the 
coding is assessed. Risk models relying solely on informa-
tion from IAHD are compared with risk models that rely 
on information from review of medical records regarding 
discrimination, calibration and net reclassification index. 
To assess the validity of mortality risk predicted from a 
model based on IAHD, the correlation to the mortality 
risk predicted from a model based on medical records is 
calculated.
Planned subgroup analyses will be conducted to 
assess the stability of results. Since previous research has 
shown that sepsis is poorly reported outside the inten-
sive care unit (ICU),18 the validity of the coding abstrac-
tion strategies will be examined among patients that 
were treated on an ICU and among patients not treated 
on an ICU. Subgroup analyses will also be conducted 
for patients discharged in the years 2015, 2016 and 2017 
to assess the stability of predictive accuracy across time. 
To assess the variability of sensitivity, specificity and 
predictive value across the participating study centres 
a logistic regression model with random effects that is 
an extension of the model presented by Coughlin et 
al35 will be calculated. The amount of missing data will 
be reported, especially regarding the information that 
is necessary to judge the presence of sepsis based on 
medical records. Analyses will be adjusted for sampling 
weights where appropriate. A detailed analysis plan will 
be written before the analysis of the 10 000 study cases 
will be conducted.
Sample size calculation
The sample size was calculated regarding the primary 
endpoint of the study—the sensitivity of the coding of 
sepsis with organ dysfunction (ICD-10- GM codes R65.1 
and R57.2) in IAHD. In the pilot study, the sensitivity was 
estimated to be 0.39. To estimate sensitivity with a 95% 
CI of width ±0.03 a sample of number of about 850 true 
sepsis cases with organ dysfunction according to judge-
ment of record data are necessary. In our pilot study, the 
rate of such cases in the sample was 8.6% resulting in 
necessary total sample of number of about 10 000 hospital 
episodes. This sample size also allows for an exact estimate 
of the proportion of true sepsis with organ dysfunction 
in the validation study sample (95% CI of width 0.005). 
Finally given this sample size, also risk models for hospital 
mortality among these cases can be calculated involving 
more than 30 predictors, given a mortality of 45%, what 
results in 380 deceased cases.36
National incidence study
Design
Using estimates of sensitivity and specificity of sepsis 
coding in IAHD, adjusted estimates of the yearly inci-
dence of hospital- treated sepsis are calculated by analysing 
German national IAHD data of the years 2015–2017.17
Setting
In Germany, hospitals are reimbursed based on a DRG 
system. Every year a standardised data set is transferred to 
the federal Institute of Hospital Reimbursement (Institut 
für das Entgeltsystem im Krankenhaus; InEK) by every 
hospital providing acute care (legal base: §21 KHEntgG). 
These data are passed to the Federal Bureau of Statistics 
and can be analysed for research purposes.
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Sample
The same inclusion criteria as described for the valida-
tion study (inpatient cases, DRG- billing, age of at least 
15 years, discharge in years 2015–2017) are applied to 
German national IAHD, which are used to calculate an 
adjusted national incidence of hospital- treated sepsis.
Procedure
National IAHD are hosted by the Federal Bureau of 
statistics and can be accessed via a form of remote data 
processing. Based on completely anonymised sample data 
files, statistical syntaxes are written and sent to the Federal 
Bureau where they are applied to the original data files. 
Output files are then transferred back to the researcher.
Statistical analysis
German national IAHD have been used previously to calcu-
late yearly incidence proportions of sepsis.11 12 These were 
calculated by obtaining the number of hospital episodes 
with ICD-10- GM coded sepsis per year and dividing them 
by the size of the German population within the same 
year. Rogan and Gladen17 presented a method to calcu-
late the prevalence of a disease, if the disease is identified 
by an imperfect screening test. The observed prevalence 
is adjusted by a formula involving the sensitivity and the 
specificity of the screening test. Therefore, sensitivity and 
specificity of a coding abstraction strategy can be used 
to calculate an adjusted prevalence of hospital episodes 
with sepsis and from this an adjusted number of hospital 
episodes with sepsis. Methods to calculate CIs for the 
adjusted prevalence also are available.37 38 Adapting these 
methods, an adjusted incidence proportion of sepsis with 
a CI can be calculated using the sensitivity and specificity 
estimates of coding abstraction strategies from the valida-
tion study.
Sample size calculation
Since the national IAHD of Germany involve more than 
18 Million inpatient cases per year and more than 130 000 
cases with codes for sepsis with organ dysfunction or 
shock, test power will not be an issue in the analysis of 
these data.
Project organisation
The project is coordinated at the University Hospital Jena 
led by a senior research physician (KR) and involving an 
epidemiologist (DS), a study physician (HD) and two 
data managers. Local study teams led by a senior research 
physician and involving study physicians and study nurses 
run the project at the study centres. Each participating 
study centre receives funding for a 50% full- time equiva-
lent for study physicians over 6 months and 50% full- time 
equivalent for study nurses over 8 months.
Project status
In March 2020, the training and validation phase have been 
completed and the documentation of data from medical 
records for the main study has been begun in all 10 study 
centres. It is planned to begin analyses in September 2020 
and to finalise the results report in October 2020. Based 
on this report, the expert panel discussions are planned 
to be held in October 2020 leading to a draft for a memo-
randum to be available in December 2020.
Patient and public involvement
An expert panel is involved in interpretation and dissemi-
nation of results (see the section ‘Dissemination’).
Limitations
This study has a limitation of generalisability. It is only 
conducted in Germany and results could not be applied to 
other countries where IAHD have different structure and 
different rules apply for coding of diagnoses. The sample 
of the validation study consists of university and tertiary 
care hospitals and it is unclear if primary or secondary 
care hospitals would show a different validity of coding 
of sepsis in IAHD. Our calculation of an adjusted inci-
dence estimate in the national incidence study is based 
on the assumption that sensitivity and specificity of sepsis 
coding in our sample of ten hospitals can be applied to 
the full population of German hospitals. Given the selec-
tive nature of the study sample, this might not be the 
case. A general disadvantage of IAHD is the scarce clin-
ical information they contain. Electronic health record 
data have been shown to have much greater validity for 
sepsis surveillance,39 40 but no multicentre data bases with 
electronic health record data are available in Germany 
yet—like in many other countries. Therefore, our study 
seeks the validation and improvement of the usefulness 
of the available data sources.
ETHICS AND DISSEMINATION
Ethics
This study was approved by the ethics commission of the 
Jena University Hospital (No. 2018–1065- Daten). The 
processing of data is conducted based on art. 9 par 2 lit. 
i, j EU- GDPR, which allow processing of health data for 
ensuring quality and safety of healthcare and for scientific 
research. The need for informed consent was waived by 
the ethics commission and the data protection officer of 
the Jena University Hospital. To protect the rights and 
interests of the patients, data are only processed in pseud-
onymised form. Anonymisation of data is conducted after 
completion of the project.
Dissemination
The results will be published in peer- reviewed journals. To 
also influence decision- makers, a memorandum will be 
written, based on discussions of study results by an expert 
panel. The aim of the discussions is to formulate recom-
mendations to increase the utility of IAHD for surveil-
lance and quality management of sepsis. Strategies for 
improving the utility could involve linkage of additional 
data—like laboratory results or vital signs—improvement 
of physician documentation in charts, development of 
specialised procedures for coding of sepsis in IAHD and 
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training of coding staff,18 or changing of legislation and 
development of financial incentives for correct coding. 
The planned panel will involve experts on quality manage-
ment, health services research, health administrative 
data, intensive care, and medical controlling and billing.
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